The honest answer is that it depends on which peptide, who is prescribing it, where it came from and whether anyone is monitoring you. Here is how to tell those cases apart.
“Are peptides safe?” is the wrong shape of question, in the same way “are tablets safe?” would be. Peptides are a broad class of molecules, not a single product. Some are TGA-registered medicines with large human trials behind them. Some are compounded preparations with promising animal data and very little human evidence. Some are sold online by people who are not clinicians at all. Those three situations carry completely different risks, and lumping them together is how people get hurt.
Before you can judge risk, you need to know which of these you are actually looking at. Every compound guide on this site is labelled with its Australian status for exactly this reason.
| Category | What it means | Examples |
|---|---|---|
| TGA-registered | Evaluated by the Therapeutic Goods Administration for quality, safety and efficacy, listed on the ARTG, with approved product information and formal adverse-event reporting. | Semaglutide, tirzepatide, testosterone products used in TRT |
| Compounded (S4) | Prescription-only, made by a compounding pharmacy for an individual patient. Not evaluated or registered by the TGA. Quality depends entirely on the pharmacy. | BPC-157, TB-500, CJC-1295, ipamorelin |
| Grey market | Sold online as “research chemicals” or “not for human use.” No prescription, no pharmacy, no identity, purity or sterility guarantee, and no recourse when something goes wrong. | Anything you can add to a shopping cart without a consultation |
The gap between the first two rows is the single most useful thing to understand in this space — we have written it up in full at compounded vs registered medicines. The gap between the second and third rows is the difference between a medicine and a gamble.
A lot of peptide marketing quotes studies that are real but do not mean what the marketing implies. The distinction that matters is preclinical versus clinical:
Most of the repair and recovery peptides sit firmly in the first group. The evidence for BPC-157, for example, is overwhelmingly rodent data; that is genuinely interesting, and it is genuinely not the same as a human safety profile. By contrast the GLP-1 medicines used in weight management have tens of thousands of patients in published trials. Being honest about which is which is not scepticism — it is the only way to weigh a real risk against a real benefit.
Absence of evidence also cuts both ways. “No reported side effects” for a compounded peptide usually means nobody has run a trial large enough or long enough to detect them, not that none exist. Long-term safety data for most of these compounds simply does not exist yet.
In practice, harm in this space rarely comes from the molecule alone. It comes from the circumstances around it:
Grey-market vials have been found to contain the wrong compound, the wrong quantity, bacterial contamination or nothing active at all. A compounding pharmacy operating under Australian standards is a completely different proposition to an unregulated overseas seller.
Treating a symptom without knowing its cause can mask something that needed investigating. Fatigue and low libido, for instance, have a long list of possible causes — only some of which are hormonal.
Several of these therapies change measurable things in your blood. Monitoring is what turns a developing problem into an adjustment rather than an emergency. A script with no follow-up removes that safety net.
Existing conditions, other medications, pregnancy or planned pregnancy, cancer history and family history all change the calculation. A prescriber who never asked cannot have accounted for them.
Most of these are injectables. Poor technique and poor sterile practice cause infections, abscesses and injection-site reactions independently of whatever is in the vial.
Many peptides and hormones are prohibited in sport at all times. If you compete under an anti-doping code, or work somewhere that tests, check the current prohibited list before you start — not after.
None of the above means these therapies are off limits. It means the structure around them does most of the work of keeping them safe:
If a provider skips the assessment, will not tell you who the prescriber is, or ships product without a consultation, the problem is not the peptide. Our questions to ask a clinic page turns all of this into a list you can take into a first appointment, and before you start covers what to sort out in advance.
Every clinic listed operates under a registered prescriber and a doctor-supervised model. Free to enquire, and you choose who receives your details.